查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750733

自體免疫疾病診斷市場規模、佔有率、趨勢分析報告：按類型、產品類型、測試類型、最終用途、地區、細分市場預測，2025-2030 年

Autoimmune Disease Diagnostics Market Size, Share & Trends Analysis Report By Type (Systemic Autoimmune Disease Diagnostics, Localized Autoimmune Disease Diagnostics), By Product, By Test Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 129 Pages | 商品交期: 2-10個工作天內

價格

自體免疫疾病診斷市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球自體免疫疾病診斷市場規模預計到2030年將達到82億美元，2025年至2030年期間的複合年成長率為6.18%。

政府機構和組織正在努力控制這些高昂的醫療保健成本，同時為患者提供更好的診斷和治療方案，從而增加美國國立衛生研究院對自體免疫疾病相關研究和開發項目的資金。

此外，政府推出的旨在遏制這些疾病發生和開發可行的診斷和治療方案的有利舉措預計將在預測期內推動市場成長。

自體免疫診斷程序的興起，使得對能夠更快、更有效地提供結果的儀器和設備的需求日益成長。為了應對不斷成長的程序量，診斷實驗室正在迅速走向自動化。實驗室自動化有助於減少工作量，縮短週轉時間，並有助於獲得標準化、可重複的結果。

自體免疫疾病診斷市場報告重點

  • 局部自體免疫疾病診斷領域將佔據市場主導地位，到 2024 年的收入佔有率將達到 64.25%。
  • 2024 年，消耗品和檢測試劑部門佔據了最大的收益佔有率，為 70.43%。所有臨床實驗室診斷測試都使用測試套件、試劑和抗體。
  • 按測試類型分類，抗核抗體測試佔據市場主導地位，2024 年的收益佔有率為 42.62%。該細分市場的成長受到可負擔性、高靈敏度和充足可用性的推動。
  • 醫院部門在市場中佔據主導地位，2024 年的收益佔有率為 53.32%。這一高佔有率歸因於醫院擴大採用自體免疫疾病診斷來治療各種疾病。
  • 預計北美將主導全球自體免疫疾病診斷市場，2024 年的收入佔有率將達到自體免疫%。預計亞太地區在 2024 年至 2030 年期間的複合年成長率最快。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析

第4章 業務類型分析

  • 自體免疫疾病診斷市場：按類型變化分析
  • 系統性自體免疫疾病的診斷
    • 系統性自體免疫疾病診斷市場，2018-2030
    • 類風濕性關節炎的診斷
    • 僵直性脊椎炎的診斷
    • 全身性紅斑性狼瘡（SLE）的診斷
    • 其他系統性自體免疫疾病的診斷
  • 局部疾病診斷
    • 2018-2030年局部疾病診斷市場
    • 多發性硬化症的診斷
    • 1型糖尿病的診斷
    • 橋本甲狀腺炎的診斷
    • 特發性血小板減少紫斑症（ITP）的診斷
    • 其他局部自體免疫疾病的診斷

第5章 產品類型業務分析

  • 自體免疫疾病診斷市場：按產品類型進行的變化分析
  • 裝置
  • 耗材和檢測試劑

6. 按測試類型進行的業務分析

  • 自體免疫疾病診斷市場：按測試類型波動分析
  • 抗核抗體檢測
  • 自體抗體檢測
  • C反應蛋白（CRP）
  • 全血球計數（CBC）
  • 尿液檢查
  • 其他

第7章 按最終用途分類的業務分析

  • 自體免疫疾病診斷市場：依最終用途進行的變化分析
  • 醫院
  • 診斷中心
  • 其他

第8章區域業務分析

  • 2024 年及 2030 年各地區自體免疫疾病診斷市場佔有率
  • 北美洲
    • SWOT分析
    • 2018-2030年北美自體免疫疾病診斷市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • SWOT分析
    • 2018-2030年歐洲自體免疫疾病診斷市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • SWOT分析
    • 2018-2030年亞太地區自體自體免疫疾病診斷市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 2018-2030年拉丁美洲自體免疫疾病診斷市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 2018-2030年中東及非洲自體免疫疾病診斷市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 2024年公司市場佔有率分析
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthcare Private Limited
    • Abbott
    • Beckman Coulter, Inc.
    • Danaher Corporation
    • Quest Diagnostics
    • EUROIMMUN Medizinische Labordiagnostika AG
    • Nova Diagnostics Pte Ltd.
    • BIOMERIEUX
    • Hemagen Diagnostics, Inc.
Product Code: 978-1-68038-292-1

Autoimmune Disease Diagnostics Market Growth & Trends:

The global autoimmune disease diagnostics market size is estimated to reach USD 8.20 billion by 2030, expanding at a CAGR of 6.18% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases.

Moreover, the presence of favorable government initiatives aimed at curbing the incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.

Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results.

Autoimmune Disease Diagnostics Market Report Highlights:

  • The localized autoimmune disease diagnostics segment dominated the market and accounted for a revenue share of 64.25% in 2024.
  • The consumables & assays segment accounted for the largest revenue share of 70.43% in 2024. Every laboratory diagnostic test utilizes test kits, reagents, and antibodies.
  • In terms of test type, the antinuclear antibody tests dominated the market with a revenue share of 42.62% in 2024. The growth of this segment is attributed to affordability, high sensitivity, and extensive availability.
  • The hospital segment dominated the market in 2024 with a revenue share of 53.32%. The high share is attributed to the increased adoption of autoimmune disease diagnostic practices in hospitals for various diseases.
  • The North America autoimmune disease diagnostics market dominated the global industry and accounted for a revenue share of 42.70% in 2024. The Asia Pacific autoimmune disease diagnostics market is anticipated to witness a fastest CAGR from 2024 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type segment
      • 1.1.1.2. Product segment
      • 1.1.1.3. Test Type segment
      • 1.1.1.4. End use segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Test Type Snapshot
  • 2.3. Product and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Presence of research funding programs
      • 3.2.1.2. Presence of favorable government initiatives
      • 3.2.1.3. Growing patient awareness levels
      • 3.2.1.4. Technological innovation in the form of lab automation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Slow diagnostic result turnaround times and lack of skilled healthcare practitioners
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Type Business Analysis

  • 4.1. Autoimmune Disease Diagnostics Market: Type Movement Analysis
  • 4.2. Systemic Autoimmune Disease Diagnostics
    • 4.2.1. Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.2. Rheumatoid Arthritis Diagnostics
      • 4.2.2.1. Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.3. Ankylosing Spondylitis Diagnostics
      • 4.2.3.1. Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.4. Systemic Lupus Erythematosus (SLE) Diagnostics
      • 4.2.4.1. Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.2.5. Other Systemic Autoimmune Disease Diagnostics
      • 4.2.5.1. Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 4.3. Localized Disease Diagnostics
    • 4.3.1. Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.2. Multiple sclerosis diagnostics
      • 4.3.2.1. Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.3. Type 1 Diabetes Diagnostics
      • 4.3.3.1. Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.4. Hashimoto's Thyroiditis Diagnostics
      • 4.3.4.1. Hashimoto's Thyroiditis Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.5. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics
      • 4.3.5.1. Idiopathic Thrombocytopenic Purpura (ITP) diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.6. Other Localized Autoimmune Disease Diagnostics
      • 4.3.6.1. Other Localized Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Autoimmune Disease Diagnostics Market: Product Movement Analysis
  • 5.2. Instruments
    • 5.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 5.3. Consumables and Assays
    • 5.3.1. Consumables and Assays Market, 2018 - 2030 (USD Million)

Chapter 6. Test Type Business Analysis

  • 6.1. Autoimmune Disease Diagnostics Market: Test Type Movement Analysis
  • 6.2. Antinuclear Antibody Tests
    • 6.2.1. Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
  • 6.3. Autoantibody Tests
    • 6.3.1. Autoantibody Tests Market, 2018 - 2030 (USD Million)
  • 6.4. C-reactive Protein (CRP)
    • 6.4.1. C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
  • 6.5. Complete Blood Count (CBC)
    • 6.5.1. Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
  • 6.6. Urinalysis
    • 6.6.1. Urinalysis Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Autoimmune Disease Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3. Diagnostic Centers
    • 7.3.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Autoimmune Disease Diagnostics Market Share By Region, 2024 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Canada Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Mexico Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. France Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Italy Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Spain Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.8. UK
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. UK Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Sweden Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Norway Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.11. Denmark
      • 8.3.11.1. Key Country Dynamics
      • 8.3.11.2. Target Disease Prevalence
      • 8.3.11.3. Competitive Scenario
      • 8.3.11.4. Regulatory Framework
      • 8.3.11.5. Denmark Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Japan Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. China Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. India Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Australia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Thailand Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. South Korea Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. South Africa Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Saudi Arabia Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. UAE Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Kuwait Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. F. Hoffmann-La Roche Ltd
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Siemens Healthcare Private Limited
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Abbott
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Beckman Coulter, Inc.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Danaher Corporation
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Quest Diagnostics
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. EUROIMMUN Medizinische Labordiagnostika AG
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Nova Diagnostics Pte Ltd.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. BIOMERIEUX
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Hemagen Diagnostics, Inc.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Autoimmune Disease Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Global Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 7 Global Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 8 North America Autoimmune Disease Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 North America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 12 North America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Autoimmune Disease Diagnostics Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Autoimmune Disease Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Autoimmune Disease Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
  • Table 20 Canada Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Mexico Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 29 Europe Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 UK Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 UK Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 33 UK Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Germany Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 Germany Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 Germany Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 France Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 France Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 France Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 41 France Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 Italy Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 49 Spain Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Sweden Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 53 Sweden Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Norway Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Norway Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 57 Norway Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 Denmark Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Denmark Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Denmark Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 61 Denmark Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 70 Japan Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 71 China Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 China Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 74 China Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 75 India Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 India Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 India Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 78 India Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 82 Australia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 83 Thailand Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 85 Thailand Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 86 Thailand Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 87 South Korea Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 South Korea Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 South Korea Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 90 South Korea Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Latin America Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 95 Latin America Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 99 Brazil Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 103 Argentina Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 104 MEA Autoimmune Disease Diagnostics Market, by country, 2018 - 2030 (USD Million)
  • Table 105 MEA Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 MEA Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 MEA Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 108 MEA Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 112 South Africa Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 120 UAE Autoimmune Disease Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Autoimmune Disease Diagnostics Market, by Type, 2018 - 2030 (USD)
  • Table 122 Kuwait Autoimmune Disease Diagnostics Market, By Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Autoimmune Disease Diagnostics Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Autoimmune Disease Diagnostics Market, By End Use, 32018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Autoimmune Disease Diagnostics Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 Swot Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Autoimmune Disease Diagnostics Market: Type Outlook and Key Takeaways
  • Fig. 15 Autoimmune Disease Diagnostics Market: Type Movement Analysis & Market Share 2024 & 2030
  • Fig. 16 Implementation Of the Amp Ra/SLE Program, By Research Phase
  • Fig. 17 Global Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Rheumatoid Arthritis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Ankylosing Spondylitis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Systemic Lupus Erythematosus (SLE) Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Other Systemic Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Localized Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Multiple Sclerosis Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Type 1 Diabetes Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Hashimoto's Thyroiditis Diagnostics Market, 2013 - 2025 (USD Millio2018 - 2030 (USD Million)
  • Fig. 26 Global Idiopathic Thrombocytopenic Purpura Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Other Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 28 Autoimmune Disease Diagnostics Market: Product Outlook and Key Takeaways
  • Fig. 29 Autoimmune Disease Diagnostics Market: Product Movement Analysis & Market Share
  • Fig. 30 Global Instruments Market, 2018 - 2030 (USD Million)
  • Fig. 31 Global Consumables and Assays Tests Market, 2018 - 2030 (USD Million)
  • Fig. 32 Autoimmune Disease Diagnostics Market: Test Type Outlook and Key Takeaways
  • Fig. 33 Autoimmune Disease Diagnostics Market: Test Type Movement Analysis & Market Share
  • Fig. 34 Global Antinuclear Antibody Tests Market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Autoantibody Tests Market, 2018 - 2030 (USD Million)
  • Fig. 36 Global C-Reactive Protein (CRP) Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Complete Blood Count (CBC) Market, 2018 - 2030 (USD Million)
  • Fig. 38 Global Urinalysis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 40 Autoimmune Disease Diagnostics Market: End Use Outlook and Key Takeaways
  • Fig. 41 Autoimmune Disease Diagnostics Market: End Use Movement Analysis & Market Share
  • Fig. 42 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 43 Global Diagnostic Centres Market, 2018 - 2030 (USD Million)
  • Fig. 44 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 45 Regional Marketplace: Key Takeaways
  • Fig. 46 Regional Outlook, 2024 & 2030
  • Fig. 47 Regional Market Dashboard
  • Fig. 48 Regional Market Place: Key Takeaways
  • Fig. 49 North America, Swot Analysis
  • Fig. 50 Europe, Swot Analysis
  • Fig. 51 Asia Pacific, Swot Analysis
  • Fig. 52 Latin America, Swot Analysis
  • Fig. 53 MEA, Swot Analysis
  • Fig. 54 North America
  • Fig. 55 North America Autoimmune Disease Diagnostics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Key Country Dynamics
  • Fig. 57 U.S. America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Canada Key Country Dynamics
  • Fig. 59 Canada America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Key Country Dynamics
  • Fig. 61 Mexico America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 63 UK Key Country Dynamics
  • Fig. 64 UK America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 65 Germany Key Country Dynamics
  • Fig. 66 Germany America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 France Key Country Dynamics
  • Fig. 68 France America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 69 Italy Key Country Dynamics
  • Fig. 70 Italy America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 71 Spain Key Country Dynamics
  • Fig. 72 Spain America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Sweden Key Country Dynamics
  • Fig. 74 Sweden America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 75 Norway Key Country Dynamics
  • Fig. 76 Norway America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 77 Denmark Key Country Dynamics
  • Fig. 78 Denmark America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Asia Pacific America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 80 Japan Key Country Dynamics
  • Fig. 81 Japan America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 China Key Country Dynamics
  • Fig. 83 China America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 84 India Key Country Dynamics
  • Fig. 85 India America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 86 Australia Key Country Dynamics
  • Fig. 87 Australia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand Key Country Dynamics
  • Fig. 89 Thailand America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea Key Country Dynamics
  • Fig. 91 South Korea America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil Key Country Dynamics
  • Fig. 94 Brazil America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 95 Argentina Key Country Dynamics
  • Fig. 96 Argentina America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 97 Middle East and Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa Key Country Dynamics
  • Fig. 99 South Africa America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 100 Saudi Arabia Key Country Dynamics
  • Fig. 101 Saudi Arabia America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 UAE Key Country Dynamics
  • Fig. 103 UAE America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 104 Kuwait Key Country Dynamics
  • Fig. 105 Kuwait America Autoimmune Disease Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 106 Strategy Mapping